Rare diseases
Investigational molecules
Locations
Back to Portugal680 clinical trials in Vila Nova De Gaia, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)PortugalStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
PortugalStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
PortugalLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
PortugalStudy on the Effects of Folate-Based Liposomes with Methotrexate for Patients with Moderate-to-Severe Rheumatoid Arthritis
PortugalStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
PortugalSafety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study
PortugalWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
PortugalStudy comparing two forms of cagrilintide with placebo for weight loss in adults with overweight or obesity
PortugalLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
PortugalStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
PortugalStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancer, breast cancer, and multiple myeloma treatments. Studies include evaluations of novel therapies for both early-stage and metastatic conditions.
Research encompasses targeted therapies and combination treatments aimed at improving patient outcomes.
Comprehensive studies investigating treatments for various autoimmune conditions, including Sjögren's Syndrome and systemic sclerosis. Focus on developing targeted therapies for immune system regulation.
Evaluating novel biological therapies to address complex autoimmune manifestations.
Research focused on obesity management and cardiovascular health. Studies evaluate new therapeutic approaches for weight management and cardiovascular disease prevention.
Investigating innovative treatments to address growing metabolic health challenges.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
